Ignite Creation Date:
2024-05-05 @ 11:56 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00185172
Status:
COMPLETED
Last Update Posted:
2008-04-29
First Post:
2005-09-12
Brief Title:
Olmesartan in Essential Hypertension
Sponsor:
Sankyo Pharma Gmbh
Organization:
Daiichi Sankyo
Organization Data
Organization:
Daiichi Sankyo
Class:
INDUSTRY
Study ID:
SP-OLM-01-00
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sankyo Pharma Gmbh
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Senior Manager Study Coordinator
Old Organization:
Daiichi Sankyo Europe GmbH